SHANGHAI JUNSHI BIOSCIENCES CO., LTD.*


                                       1877




2020   11   12

                                        
                                                         JS001
  SARS-CoV-2                               JS016


                                              JS001                          JS016


   2018     12   17
                           NMPA                         2019     2
                               PD-1                II
                                  1




                      HMO-JS001-                         128         97.7%     28.9%
                       II-CRP-01



                                   1
                ORIENT-1                               96      99%       33.3%




                SHR-1210-                              75      100%      26.7%
                  II-204




                                                     PD-1




                       (ORR)        17.3%              (DCR)     57.5%
        (mOS)     22.2   12                   67.3%

        PD-1                         (ORR)   16.7%                    (DCR)
38.2%              (mOS) 12.1         12               50.6%




                                      PD-1




                                2
            www.clinicaltrials.gov                           ACTIV-3
               COVID-19                        LY-CoV555
                                                III
              JS016                                     LY-CoV555
    JS016                             2             I
                                          JS016
    Ib/II                                JS016               1
              LY-CoV555     II          BLAZE-1 NCT04427501


                        2020     11   12
                                                              2020 0050




                2020   11   13




      Roy Steven Herbst

*




                                           3